Monica M. Bertagnolli, MD, FACS, FASCO, and W. Kimryn Rathmell, MD, PhD, have stepped down as directors of the NIH and NCI as ...
Cancellations of NIH grant review panels, in particular, could affect cancer research grants and funding. In these NIH grant ...
Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...
A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in approving crucial clinical trials.
CNN on MSN13d
NIH interim director comes from its research ranks but is known for questioning Covid-19 vaccine mandatesDr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.
Following President Trump’s inauguration, the flurry of executive orders and funding freezes introduced uncertainty into the ...
A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of heightened sensitivity about how the Trump administration will shift the agencies’ ...
TAMPA, FL / ACCESS Newswire / February 5, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC PINK:CTTH) is pleased to announce adding Dr. Katherine Cole as an Independent Director for CTT.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback